Cartesian Therapeutics Inc header image

Cartesian Therapeutics Inc

RNAC

Equity

ISIN null / Valor 134256445

NASDAQ (2026-04-06)
USD 6.24-0.32%

Cartesian Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cartesian Therapeutics Inc. is a biotechnology company specializing in the development of RNA cell therapies for autoimmune, oncologic, and respiratory diseases. The company leverages its proprietary RNA Armory platform to engineer cell therapies that can be precisely controlled and directed to target specific disease mechanisms. Cartesian's lead product candidates include Descartes-08, an RNA-engineered cell therapy for myasthenia gravis, and Descartes-11, aimed at treating multiple myeloma. The company is focused on advancing these therapies through clinical trials to address unmet medical needs in these complex conditions.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-37.6%1Y
-84.1%3Y
-95.2%5Y

Performance

88.3%1Y
95.5%3Y
88.9%5Y

Volatility

Market cap

165 M

Market cap (USD)

Daily traded volume (Shares)

92,947

Daily traded volume (Shares)

1 day high/low

19.47 / 18.13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Keros Therapeutics Inc
Keros Therapeutics Inc Keros Therapeutics Inc Valor: 53581630
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 11.87
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.02%USD 11.90
SFS Group Ltd
SFS Group Ltd SFS Group Ltd Valor: 23922930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.67%CHF 118.00
ALSO Holding AG
ALSO Holding AG ALSO Holding AG Valor: 2459027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%CHF 141.20
SoftwareOne Holding Ltd.
SoftwareOne Holding Ltd. SoftwareOne Holding Ltd. Valor: 49645150
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.37%CHF 6.30
Landis+Gyr Group Ltd
Landis+Gyr Group Ltd Landis+Gyr Group Ltd Valor: 37115349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.39%CHF 51.00
Jamieson Wellness Inc
Jamieson Wellness Inc Jamieson Wellness Inc Valor: 36959481
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%CAD 34.71
Huber + Suhner AG
Huber + Suhner AG Huber + Suhner AG Valor: 3038073
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.54%CHF 184.60
Infineon Technologies AG
Infineon Technologies AG Infineon Technologies AG Valor: 1038049
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.96%EUR 38.96
Nemetschek SE
Nemetschek SE Nemetschek SE Valor: 329782
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.97%EUR 64.80